These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
824 related articles for article (PubMed ID: 23934131)
21. Differential effects of the antioxidant n-acetylcysteine on the production of catabolic mediators in IL-1beta-stimulated human osteoarthritic synoviocytes and chondrocytes. Roman-Blas JA; Contreras-Blasco MA; Largo R; Alvarez-Soria MA; Castañeda S; Herrero-Beaumont G Eur J Pharmacol; 2009 Nov; 623(1-3):125-31. PubMed ID: 19765584 [TBL] [Abstract][Full Text] [Related]
22. Pirfenidone attenuates IL-1β-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-κB activity. Choi YH; Back KO; Kim HJ; Lee SY; Kook KH Exp Eye Res; 2013 Aug; 113():1-8. PubMed ID: 23664858 [TBL] [Abstract][Full Text] [Related]
23. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis. Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214 [TBL] [Abstract][Full Text] [Related]
24. Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis. Gui H; Liu X; Wang ZW; He DY; Su DF; Dai SM Rheumatology (Oxford); 2014 May; 53(5):802-9. PubMed ID: 24440992 [TBL] [Abstract][Full Text] [Related]
25. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation. Xue M; McKelvey K; Shen K; Minhas N; March L; Park SY; Jackson CJ Rheumatology (Oxford); 2014 Dec; 53(12):2270-9. PubMed ID: 24982240 [TBL] [Abstract][Full Text] [Related]
26. Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: involvement of ERK, JNK, AP-1, and NF-kappaB. Yang CM; Luo SF; Hsieh HL; Chi PL; Lin CC; Wu CC; Hsiao LD J Cell Physiol; 2010 Aug; 224(2):516-26. PubMed ID: 20432452 [TBL] [Abstract][Full Text] [Related]
27. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts. Ospelt C; Brentano F; Jüngel A; Rengel Y; Kolling C; Michel BA; Gay RE; Gay S Arthritis Rheum; 2009 Feb; 60(2):355-63. PubMed ID: 19180502 [TBL] [Abstract][Full Text] [Related]
28. Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocation. Zhong HM; Ding QH; Chen WP; Luo RB Int Immunopharmacol; 2013 Oct; 17(2):329-35. PubMed ID: 23856614 [TBL] [Abstract][Full Text] [Related]
29. [Enhancement by FK506 of triptolide-induced inhibition of expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts]. Yao HP; Shao XT; Sun WJ; Shao CS; Zhang LH Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):277-82. PubMed ID: 12621554 [TBL] [Abstract][Full Text] [Related]
30. 4-Phenylbutyric acid, a potent endoplasmic reticulum stress inhibitor, attenuates the severity of collagen-induced arthritis in mice via inhibition of proliferation and inflammatory responses of synovial fibroblasts. Choi Y; Lee EG; Jeong JH; Yoo WH Kaohsiung J Med Sci; 2021 Jul; 37(7):604-615. PubMed ID: 33759334 [TBL] [Abstract][Full Text] [Related]
31. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy. Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684 [TBL] [Abstract][Full Text] [Related]
32. Luteolin suppresses IL-1beta-induced cytokines and MMPs production via p38 MAPK, JNK, NF-kappaB and AP-1 activation in human synovial sarcoma cell line, SW982. Choi EM; Lee YS Food Chem Toxicol; 2010 Oct; 48(10):2607-11. PubMed ID: 20600535 [TBL] [Abstract][Full Text] [Related]
33. Short-term hyperthermia prevents activation of proinflammatory genes in fibroblast-like synoviocytes by blocking the activation of the transcription factor NF-kappaB. Markovic M; Stuhlmeier KM J Mol Med (Berl); 2006 Oct; 84(10):821-32. PubMed ID: 16955275 [TBL] [Abstract][Full Text] [Related]
34. The pattern-recognition receptor nucleotide-binding oligomerization domain--containing protein 1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts. Yokota K; Miyazaki T; Hemmatazad H; Gay RE; Kolling C; Fearon U; Suzuki H; Mimura T; Gay S; Ospelt C Arthritis Rheum; 2012 May; 64(5):1329-37. PubMed ID: 22143988 [TBL] [Abstract][Full Text] [Related]
35. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts. Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087 [TBL] [Abstract][Full Text] [Related]
36. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Ahmed S; Pakozdi A; Koch AE Arthritis Rheum; 2006 Aug; 54(8):2393-401. PubMed ID: 16869002 [TBL] [Abstract][Full Text] [Related]
37. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs. Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133 [TBL] [Abstract][Full Text] [Related]
38. TACE-dependent amphiregulin release is induced by IL-1β and promotes cell invasion in fibroblast-like synoviocytes in rheumatoid arthritis. Liu FL; Wu CC; Chang DM Rheumatology (Oxford); 2014 Feb; 53(2):260-9. PubMed ID: 24196392 [TBL] [Abstract][Full Text] [Related]
39. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis. Smeets TJ; Dayer JM; Kraan MC; Versendaal J; Chicheportiche R; Breedveld FC; Tak PP Arthritis Rheum; 2000 Feb; 43(2):270-4. PubMed ID: 10693865 [TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 suppresses nuclear factor-kappaB mediated interleukin 15 production in rheumatoid synoviocytes. Min SY; Kim WU; Cho ML; Hwang SY; Park SH; Cho CS; Kim JM; Kim HY J Rheumatol; 2002 Jul; 29(7):1366-76. PubMed ID: 12136890 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]